Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
MGI Tech Unveils Next-Generation Automation Portfolio at SLAS Europe 2025 in Germany 2025-05-22 10:38
Neurophet Participates ASNR 2025: Showcasing Clinical Utility of 'Neurophet AQUA AD' 2025-05-21 21:00
BioDlink Clinches Brazil GMP Audit to Strengthen Emerging Markets Growth 2025-05-21 20:30
China's Aphranel MagiCCrystal CaHA Filler Debuts Globally, Ushering in a New Era of Regenerative Aesthetic Medicine 2025-05-21 20:00
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine 2025-05-21 20:00
Accropeutics Announces Positive Data from Phase 2 Trial of AC-201, an oral, selective TYK2/JAK1 Inhibitor, for the treatment of Moderate-to-Severe Plaque Psoriasis 2025-05-21 08:50
Registrational Phase III AMPLIFY trial in biochemical recurrence of prostate cancer commences 2025-05-20 21:02
Minghui Pharmaceutical Announces First Patient Dosed in the Phase Ⅱ Combination Study of PD-1xVEGF Bispecific and TROP-2 ADC in Advanced NSCLC 2025-05-20 18:18
BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025 2025-05-20 18:00
WuXi XDC Received Multiple Awards from 2025 Extel (previously "Institutional Investor") Ranking in Diverse Categories 2025-05-20 09:44
United Imaging Emphasizes Differentiated Technology at ISMRM 2025 2025-05-20 00:00
Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition 2025-05-19 21:00
Porton Advanced Announces Collaboration with Hualong Biological to Accelerate MATC Cell Therapy Development for Solid Tumor Treatment Breakthroughs 2025-05-19 21:00
Datasea Secures $100 Million in 5G+AI Contracts from Major Clients, Reinforcing Strategic Expansion and Long-Term Growth 2025-05-19 20:30
2025 EASL Congress Spotlight: CG-0416 Preclinical Data Unveils A Groundbreaking Dual-Action Therapy Targeting Obesity and MASH 2025-05-17 08:41
SNS812, an innovative siRNA drug from Oneness and Microbio (Shanghai), selected for ATS 2025 oral presentation, demonstrating world-leading clinical outcomes in COVID-19 treatment 2025-05-16 23:10
Visionary: Pioneering a New Era in Cancer Screening 2025-05-16 21:30
Xuanzhu Biopharm's Xuanyuening® (BireociclibTablets) Approved for Dual Indications, Bringing Innovative Breakthroughs to Breast Cancer Treatment 2025-05-16 11:57
Datasea Reports Third Fiscal Quarter 2025 Revenue of $10.4 Million Up 653.6% Year-over-Year 2025-05-15 21:30
Dizal to Present Promising Clinical Data on Golidocitinib and DZD8586 for the Treatment of Lymphoma at the Coming International Hematology Conferences 2025-05-15 18:09
1 32 33 34 35 36 491